Cancer Health Treatment Update FDA Approves First CAR-T Therapy for Chronic Lymphocytic Leukemia Breyanzi, made from a patient’s own T cells, controlled relapsed or nonresponsive CLL in 20% of people previously treated with targeted therapies. Cancer Health Spring 2024 Check out our new print edition! Managing Neuropathy Pain Chemotherapy-induced peri­pheral neuropathy—pain, tingling, burning or numbness in the feet and hands—is common among cancer patients, but it can be managed. Lutathera Shows Promise for Some Neuroendocrine Tumors The radiopharmaceutical delayed disease progression for patients with advanced gastrointestinal or pancreatic neuroendocrine tumors. Advertisement FDA Approves First-Ever Drug for Fatty Liver Disease Fatty liver disease can lead to cirrhosis and liver cancer. People who used resmetirom (Rezdiffra) in a late-stage clinical trial showed both MASH resolution and fibrosis improvement. Biden Is Right. The U.S. Generally Pays Double That of Other Countries for Rx Drugs Americans pay significantly higher prices overall for prescription medications but less for unbranded generic drugs. News About COVID-19 See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. Newsfeed Cancer Advocates Celebrate Anniversary of the Affordable Care Act How a Breast Cancer Calculator Led to Olivia Munn’s Double Mastectomy Can a New Drug Candidate Cure Pancreatic Cancer? Many Cancer Treatment Recommendations Updated Based on Emerging Evidence Blog: National Cancer Institute Lutathera Shows Promise for Some Neuroendocrine Tumors Blood Test May Guide Who Needs Chemo After Colorectal Cancer Surgery Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies Augtyro Expands Treatment Options for Lung Cancers With ROS1 Fusions Newsfeed Cancer Advocates Celebrate Anniversary of the Affordable Care Act How a Breast Cancer Calculator Led to Olivia Munn’s Double Mastectomy Can a New Drug Candidate Cure Pancreatic Cancer? Many Cancer Treatment Recommendations Updated Based on Emerging Evidence Blog: National Cancer Institute Lutathera Shows Promise for Some Neuroendocrine Tumors Blood Test May Guide Who Needs Chemo After Colorectal Cancer Surgery Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies Augtyro Expands Treatment Options for Lung Cancers With ROS1 Fusions

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: